Cargando…

When Are Adverse Outcome Pathways and Associated Assays “Fit for Purpose” for Regulatory Decision‐Making and Management of Chemicals?

There have been increasing demands for chemical hazard and risk assessments in recent years. Chemical companies have expanded internal product stewardship initiatives, and jurisdictions have increased the regulatory requirements for the manufacture and sale of chemicals. There has also been a shift...

Descripción completa

Detalles Bibliográficos
Autores principales: Coady, Katie, Browne, Patience, Embry, Michelle, Hill, Thomas, Leinala, Eeva, Steeger, Thomas, Maślankiewicz, Lidka, Hutchinson, Tom
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771501/
https://www.ncbi.nlm.nih.gov/pubmed/30908812
http://dx.doi.org/10.1002/ieam.4153
_version_ 1783455694660304896
author Coady, Katie
Browne, Patience
Embry, Michelle
Hill, Thomas
Leinala, Eeva
Steeger, Thomas
Maślankiewicz, Lidka
Hutchinson, Tom
author_facet Coady, Katie
Browne, Patience
Embry, Michelle
Hill, Thomas
Leinala, Eeva
Steeger, Thomas
Maślankiewicz, Lidka
Hutchinson, Tom
author_sort Coady, Katie
collection PubMed
description There have been increasing demands for chemical hazard and risk assessments in recent years. Chemical companies have expanded internal product stewardship initiatives, and jurisdictions have increased the regulatory requirements for the manufacture and sale of chemicals. There has also been a shift in chemical toxicity evaluations within the same time frame, with new methodologies being developed to improve chemical safety assessments for both human health and the environment. With increased needs for chemical assessments coupled with more diverse data streams from new technologies, regulators and others tasked with chemical management activities are faced with increasing workloads and more diverse types of data to consider. The Adverse Outcome Pathway (AOP) framework can be applied in different scenarios to integrate data and guide chemical assessment and management activities. In this paper, scenarios of how AOPs can be used to guide chemical management decisions during research and development, chemical registration, and subsequent regulatory activities such as prioritization and risk assessment are considered. Furthermore, specific criteria (e.g., the type and level of AOP complexity, confidence in the AOP, as well as external review and assay validation) are proposed to examine whether AOPs and associated tools are fit for purpose when applied in different contexts. Certain toxicity pathways are recommended as priority areas for AOP research and development, and the continued use of AOPs and defined approaches in regulatory activities are recommended. Furthermore, a call for increased outreach, education, and enhanced use of AOP databases is proposed to increase their utility in chemicals management. Integr Environ Assess Manag 2019;15:633–647. © 2019 The Authors. Integrated Environmental Assessment and Management published by Wiley Periodicals, Inc. on behalf of Society of Environmental Toxicology & Chemistry (SETAC)
format Online
Article
Text
id pubmed-6771501
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-67715012019-10-03 When Are Adverse Outcome Pathways and Associated Assays “Fit for Purpose” for Regulatory Decision‐Making and Management of Chemicals? Coady, Katie Browne, Patience Embry, Michelle Hill, Thomas Leinala, Eeva Steeger, Thomas Maślankiewicz, Lidka Hutchinson, Tom Integr Environ Assess Manag Environmental Policy & Regulation There have been increasing demands for chemical hazard and risk assessments in recent years. Chemical companies have expanded internal product stewardship initiatives, and jurisdictions have increased the regulatory requirements for the manufacture and sale of chemicals. There has also been a shift in chemical toxicity evaluations within the same time frame, with new methodologies being developed to improve chemical safety assessments for both human health and the environment. With increased needs for chemical assessments coupled with more diverse data streams from new technologies, regulators and others tasked with chemical management activities are faced with increasing workloads and more diverse types of data to consider. The Adverse Outcome Pathway (AOP) framework can be applied in different scenarios to integrate data and guide chemical assessment and management activities. In this paper, scenarios of how AOPs can be used to guide chemical management decisions during research and development, chemical registration, and subsequent regulatory activities such as prioritization and risk assessment are considered. Furthermore, specific criteria (e.g., the type and level of AOP complexity, confidence in the AOP, as well as external review and assay validation) are proposed to examine whether AOPs and associated tools are fit for purpose when applied in different contexts. Certain toxicity pathways are recommended as priority areas for AOP research and development, and the continued use of AOPs and defined approaches in regulatory activities are recommended. Furthermore, a call for increased outreach, education, and enhanced use of AOP databases is proposed to increase their utility in chemicals management. Integr Environ Assess Manag 2019;15:633–647. © 2019 The Authors. Integrated Environmental Assessment and Management published by Wiley Periodicals, Inc. on behalf of Society of Environmental Toxicology & Chemistry (SETAC) John Wiley and Sons Inc. 2019-07-17 2019-07 /pmc/articles/PMC6771501/ /pubmed/30908812 http://dx.doi.org/10.1002/ieam.4153 Text en © 2019 The Authors. Integrated Environmental Assessment and Management published by Wiley Periodicals, Inc. on behalf of Society of Environmental Toxicology & Chemistry (SETAC) This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Environmental Policy & Regulation
Coady, Katie
Browne, Patience
Embry, Michelle
Hill, Thomas
Leinala, Eeva
Steeger, Thomas
Maślankiewicz, Lidka
Hutchinson, Tom
When Are Adverse Outcome Pathways and Associated Assays “Fit for Purpose” for Regulatory Decision‐Making and Management of Chemicals?
title When Are Adverse Outcome Pathways and Associated Assays “Fit for Purpose” for Regulatory Decision‐Making and Management of Chemicals?
title_full When Are Adverse Outcome Pathways and Associated Assays “Fit for Purpose” for Regulatory Decision‐Making and Management of Chemicals?
title_fullStr When Are Adverse Outcome Pathways and Associated Assays “Fit for Purpose” for Regulatory Decision‐Making and Management of Chemicals?
title_full_unstemmed When Are Adverse Outcome Pathways and Associated Assays “Fit for Purpose” for Regulatory Decision‐Making and Management of Chemicals?
title_short When Are Adverse Outcome Pathways and Associated Assays “Fit for Purpose” for Regulatory Decision‐Making and Management of Chemicals?
title_sort when are adverse outcome pathways and associated assays “fit for purpose” for regulatory decision‐making and management of chemicals?
topic Environmental Policy & Regulation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771501/
https://www.ncbi.nlm.nih.gov/pubmed/30908812
http://dx.doi.org/10.1002/ieam.4153
work_keys_str_mv AT coadykatie whenareadverseoutcomepathwaysandassociatedassaysfitforpurposeforregulatorydecisionmakingandmanagementofchemicals
AT brownepatience whenareadverseoutcomepathwaysandassociatedassaysfitforpurposeforregulatorydecisionmakingandmanagementofchemicals
AT embrymichelle whenareadverseoutcomepathwaysandassociatedassaysfitforpurposeforregulatorydecisionmakingandmanagementofchemicals
AT hillthomas whenareadverseoutcomepathwaysandassociatedassaysfitforpurposeforregulatorydecisionmakingandmanagementofchemicals
AT leinalaeeva whenareadverseoutcomepathwaysandassociatedassaysfitforpurposeforregulatorydecisionmakingandmanagementofchemicals
AT steegerthomas whenareadverseoutcomepathwaysandassociatedassaysfitforpurposeforregulatorydecisionmakingandmanagementofchemicals
AT maslankiewiczlidka whenareadverseoutcomepathwaysandassociatedassaysfitforpurposeforregulatorydecisionmakingandmanagementofchemicals
AT hutchinsontom whenareadverseoutcomepathwaysandassociatedassaysfitforpurposeforregulatorydecisionmakingandmanagementofchemicals